Epidarex Capital Successfully Raises Fund to Make Significant Investments in Early-stage UK Life Sciences
In EpidarexEpidarex Capital, a leading international venture capital firm, has raised over £47.5 million to lead investments in early-stage life science and health technology companies, including spin-outs from leading research universities. Global pharmaceutical company Eli Lilly and Company participated in the final closing with a significant…